{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:29:20Z","timestamp":1786375760725,"version":"build-2736575974"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Sepsis is a life-threatening syndrome driven by a dysregulated host response to infection, characterised by dynamic and overlapping phases of hyperinflammation and immune suppression. Despite advances in critical care, effective immunomodulatory therapies remain lacking, reflecting an incomplete understanding of its complex immunopathology. Central to sepsis progression is the cytokine storm, a transient but dominant inflammatory surge that contributes to endothelial injury, microvascular dysfunction, and multi-organ failure, followed in some patients by compensatory immunosuppression. Within this evolving immunological landscape, IL-37 and IL-38 have emerged as key members of the IL-1 cytokine family with context-dependent immunoregulatory functions. IL-37 broadly suppresses NF-\u03baB- and MAPK-mediated inflammatory signalling and reprogrammes immunometabolism\n                    <jats:italic>via<\/jats:italic>\n                    mTOR inhibition, thereby attenuating pro-inflammatory cytokine production and modulating innate immune cell activity. IL-38, in contrast, exerts protective effects through regulation of inflammasome activation, promotion of regulatory T (Treg) cell responses, and suppression of effector T cell differentiation, collectively contributing to improved bacterial clearance and reduced systemic inflammation. Although both cytokines are elevated in sepsis and generally associated with disease severity, experimental evidence suggests that they function as endogenous brakes that limit excessive immune activation. However, clinical data remain heterogeneous, particularly regarding IL-10 regulation and stage-specific effects, highlighting context-dependent and compartment-specific actions. This mini-review synthesises current evidence on IL-37 and IL-38 in sepsis, emphasising their roles as integrated immunometabolic regulators rather than phase-specific mediators. We further discuss translational limitations and propose future directions centred on longitudinal immune profiling and precision immunomodulation.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1869119","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:55:45Z","timestamp":1786373745000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["IL-37 and IL-38 in sepsis: immune-metabolic rheostats in a dynamic inflammatory continuum"],"prefix":"10.3389","volume":"17","author":[{"given":"Hailong","family":"Yan","sequence":"first","affiliation":[{"name":"Department of Emergency Surgery, Shaanxi Provincial People\u2019s Hospital","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lintong","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Haematology, 3201 Hospital","place":["Hanzhong, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujuan","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Haematology, Shaanxi Provincial People\u2019s Hospital","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingbo","family":"Dang","sequence":"additional","affiliation":[{"name":"Department of Emergency Surgery, Shaanxi Provincial People\u2019s Hospital","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longyang","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Emergency Surgery, Shaanxi Provincial People\u2019s Hospital","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Emergency Surgery, Shaanxi Provincial People\u2019s Hospital","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wensheng","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Emergency Surgery, Shaanxi Provincial People\u2019s Hospital","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhou","family":"He","sequence":"additional","affiliation":[{"name":"Department of Emergency Surgery, Shaanxi Provincial People\u2019s Hospital","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shisan","family":"Bao","sequence":"additional","affiliation":[{"name":"Centre for Evidence-based Medicine, Gansu University of Chinese Medicine","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gongliang","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Emergency Surgery, Shaanxi Provincial People\u2019s Hospital","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.170149","article-title":"Clinical implications of the third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"190","author":"Fernando","year":"2018","journal-title":"CMAJ"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.36","article-title":"The immunopathology of sepsis and potential therapeutic targets","volume":"17","author":"van der Poll","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s13054-023-04762-6","article-title":"Targeting the host response in sepsis: current approaches and future evidence","volume":"27","author":"Bode","year":"2023","journal-title":"Crit Care"},{"key":"B6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41590-023-01660-5","article-title":"The pathophysiology of sepsis and precision-medicine-based\u00a0immunotherapy","volume":"25","author":"Giamarellos-Bourboulis","year":"2024","journal-title":"Nat Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nri3552","article-title":"Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-026-03940-w","article-title":"A new strategy for inflammatory regulation in sepsis: mechanisms and clinical progress of hemoperfusion techniques in correcting inflammatory homeostasis in sepsis","author":"Cao","year":"2026","journal-title":"Eur J Med Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1682306","article-title":"Cytokines in sepsis: a critical review of the literature on systemic inflammation and multiple organ dysfunction","volume":"16","author":"Vella","year":"2025","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41392-025-02178-y","article-title":"Deep insight into cytokine storm: from pathogenesis to treatment","volume":"10","author":"Nie","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1696366","article-title":"Roles of cytokine storm in sepsis progression: biomarkers, and emerging therapeutic strategies","volume":"16","author":"You","year":"2025","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201545828","article-title":"Suppression of innate inflammation and immunity by interleukin-37","volume":"46","author":"Dinarello","year":"2016","journal-title":"Eur J Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.it.2021.06.001","article-title":"The 'cytokine storm': molecular mechanisms and therapeutic prospects","volume":"42","author":"Karki","year":"2021","journal-title":"Trends Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201129","article-title":"SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology","volume":"217","author":"Veras","year":"2020","journal-title":"J Exp Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s40779-025-00678-0","article-title":"The \"cytokine storm\" in infection and sepsis: win the battle but lose the war","volume":"12","author":"Fan","year":"2026","journal-title":"Mil Med Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15737","article-title":"IL-38: A novel cytokine in systemic lupus erythematosus pathogenesis","volume":"24","author":"Xu","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/art.39328","article-title":"Brief report: interleukin-38 exerts antiinflammatory functions and is associated with disease activity in systemic lupus erythematosus","volume":"67","author":"Rudloff","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12605","article-title":"Suppression of inflammation and acquired immunity by IL-37","volume":"281","author":"Cavalli","year":"2018","journal-title":"Immunol Rev"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1619011114","article-title":"Interleukin 37 reverses the metabolic cost of inflammation, increases oxidative respiration, and improves exercise tolerance","volume":"114","author":"Cavalli","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.10.012","article-title":"The immunology of sepsis","volume":"54","author":"van der Poll","year":"2021","journal-title":"Immunity"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1564357","article-title":"The distinct roles of IL-37 and IL-38 in non-small cell lung carcinoma and their clinical implications","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1629759","article-title":"The role of IL-37 and IL-38 in rheumatoid arthritis, the potential clinical applications in precision medicine","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor NF-kappaB pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1829","article-title":"Immunosuppression in patients who die of sepsis and multiple organ failure","volume":"306","author":"Boomer","year":"2011","journal-title":"JAMA"},{"key":"B25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13054-024-04875-6","article-title":"Vascular leak in sepsis: physiological basis and potential therapeutic advances","volume":"28","author":"McMullan","year":"2024","journal-title":"Crit Care"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S403778","article-title":"Metabolic reprogramming and its regulatory mechanism in sepsis-mediated inflammation","volume":"16","author":"Liu","year":"2023","journal-title":"J Inflammation Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1679493","article-title":"Metabolic reprogramming tailors T cell immunity in sepsis","volume":"16","author":"Xian","year":"2025","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O'Neill","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1944","article-title":"IL-37 is a fundamental inhibitor of innate immunity","volume":"11","author":"Nold","year":"2010","journal-title":"Nat Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1424626112","article-title":"Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8","volume":"112","author":"Li","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2025.101952","article-title":"The stress and the alarmin-like cytokine interleukin-37 mediated extracellular and intracellular signal pathways","volume":"78","author":"Li","year":"2025","journal-title":"Semin Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2023.115816","article-title":"Interleukin-37 relieves PM2.5-triggered lung injury by inhibiting autophagy through the AKT\/mTOR signaling pathway in vivo and in vitro","volume":"269","author":"Cao","year":"2024","journal-title":"Ecotoxicol Environ Saf"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1765956","article-title":"The diagnostic and immunomodulatory role of IL-37 in pediatric sepsis","volume":"17","author":"Ma","year":"2026","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2021.01.019","article-title":"Interleukin-37 as a biomarker of mortality risk in patients with sepsis","volume":"82","author":"Wu","year":"2021","journal-title":"J Infect"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014756","article-title":"Elevated serum IL-37 concentrations in patients with sepsis","volume":"98","author":"Wang","year":"2019","journal-title":"Med (Baltimore)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-0716-1488-4_1","article-title":"Cecal ligation and puncture","volume":"2321","author":"Drechsler","year":"2021","journal-title":"Methods Mol Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2025.2495958","article-title":"IL-37 alleviates sepsis-induced lung injury by inhibiting inflammatory response through the TGF-beta\/smad3 pathway","volume":"54","author":"Guo","year":"2025","journal-title":"Immunol Invest"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/srep38955","article-title":"Interleukin-37 enhances the suppressive activity of naturally occurring CD4(+)CD25(+) regulatory T cells","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1073\/pnas.1121534109","article-title":"IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist","volume":"109","author":"van de Veerdonk","year":"2012","journal-title":"Proc Nat Acad Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy289","article-title":"Interleukin 38 protects against lethal sepsis","volume":"218","author":"Xu","year":"2018","journal-title":"J Infect Dis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14902","article-title":"Interleukin-38 protects against sepsis by augmenting immunosuppressive activity of CD4(+) CD25(+) regulatory T cells","volume":"24","author":"Ge","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6370911","article-title":"IL-38 alleviates inflammation in sepsis in mice by inhibiting macrophage apoptosis and activation of the NLRP3 inflammasome","volume":"2021","author":"Ge","year":"2021","journal-title":"Mediators Inflammation"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110619","article-title":"IL-38 suppresses macrophage M1 polarization to ameliorate synovial inflammation in the TMJ via GLUT-1 inhibition","volume":"122","author":"Luo","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00505","article-title":"Increased risk of group B streptococcus invasive infection in HIV-exposed but uninfected infants: A review of the evidence and possible mechanisms","volume":"7","author":"Dauby","year":"2016","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1869119\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:55:46Z","timestamp":1786373746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1869119\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":44,"alternative-id":["10.3389\/fimmu.2026.1869119"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1869119","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"article-number":"1869119"}}